Sunday, November 27, 2022
HomeAll Ch00 Ch00 News‘Unprecedented’, ‘Remarkable’: Cancer Study Leaves Every Patient Cancer-Free

‘Unprecedented’, ‘Remarkable’: Cancer Study Leaves Every Patient Cancer-Free

Thank You Brother, Ricin

“I believe this is the first time this has happened in the history of cancer.”

Listen To The Article Below

 

r

esults from a small cancer trial that left every patient in remission is being praised as “unprecedented” and “remarkable.”

A paper published on Sunday at The New England Journal of Medicine outlined a study of 18 rectal cancer patients who were given dostarlimab every three weeks for six months and ended up cancer-free, including the first patient who is now two years out from the trial.

“I believe this is the first time this has happened in the history of cancer,” said Dr. Luis A. Diaz Jr. said, an author of the paper, The New York Times reported.

Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center and another author of the paper, described “a lot of happy tears” at the end of the trial.

While noting the study needs replication, Dr. Kimmie Ng, a colorectal cancer expert from the Dana-Farber Cancer Institute and an associate professor at Harvard University, called the trial results “remarkable” and “unprecedented.”

 

MIDTERMS COUNTDOWN

READ THE REST @dailywire
READ MORE @CH00 CH00 NEWS
RELATED ARTICLES

Chillin @ Choo's

War Room Live 7-9 am 2-4 pm PST

Seattle
mist
45.7 ° F
47.9 °
44 °
89 %
7.8mph
100 %
Sun
46 °
Mon
42 °
Tue
37 °
Wed
36 °
Thu
37 °

ALL CHOO CHOO NEWS

Donate to $Ch00Ch00News

Ch00 Ch00 News
13036 SE Kent Kangley Rd, Suite #237
Kent, WA 98030

https://cash.app/$Ch00Ch00News

DONATE